Fate of new Galloway national park proposals to be revealed
The fate of plans to create Scotland's third national park in Galloway are set to be revealed in a Holyrood statement.The proposals - which could see the area join the Cairngorms and Loch Lomond and the Trossachs - have proved contentious.Rural Affairs Secretary Mairi Gougeon will update MSPs following a consultation carried out by NatureScot.Supporters and opponents of the plans are waiting to hear if they will move forward, be dropped or deferred until the next parliamentary session.
How did we get here?
Scotland currently has two national parks but it is more than 20 years since a new one was created.A power-sharing deal between the SNP and the Scottish Greens in 2021 agreed that "at least one" would be designated by the end of this parliamentary session in 2026.Although that political agreement collapsed in 2024, the national park process has continued.Consultation started in 2022 on where the park could be sited and Galloway was announced as the potential location for a new national park in July last year.Soon after an opposition campaign was launched and an extended consultation was carried out over 14 weeks.NatureScot has delivered its report on that feedback to the Scottish government which is now to decide the way forward.The scheme - should it proceed - would mainly be in Dumfries and Galloway but would extend into parts of Ayrshire.
For and against
Campaigners in favour of the designation say it could put the region on the map and boost the local economy.However, opponents have argued it would push up house prices, increase bureaucracy and put transport infrastructure under strain.Both have been waiting to hear the latest announcement from the Scottish government.No Galloway National Park campaign co-founder Elizabeth Hitschmann said they could not speculate what would be in the statement.
However, she said the whole idea had been a "complete dog's breakfast from the start" in which a "very small group of unrepresentative activists wrongly claimed there was overwhelming support".She said people in Galloway had "no faith" in any stage of the process including the selection of the area, consultation and the rejection of calls for a referendum and a review of the existing parks.Ms Hitschmann added: "The strength of opposition to any form of national park in Galloway is so great that we think it would be madness for any party to impose something that so many people clearly don't want."It would certainly be a wise decision to call a halt now before any more time and public money is wasted."
But Rob Lucas, who chairs of the Galloway National Park Association, called for the designation to be given to a "forgotten corner" of Scotland without delay."Galloway desperately needs a national park to give it the long-term certainty and commitment that has been missing for so long," he said."Our area has a fragile economy and remains among the poorest rural areas in the UK, despite two decades of intensive forestry, farm aggregation and large-scale renewables."We need a different approach that works with nature to build a resilient and sustainable future for local people."That call has been backed by Action to Protect Rural Scotland and the Scottish Campaign for National Parks.If a designation order was issued that would trigger another round of consultation before the status is confirmed.The earliest that could happen would be spring 2026.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
31 minutes ago
- BBC News
Head coach appointment the 'first priority' for Rangers board
Rangers' new leaders Andrew Cavenagh and Paraag Marathe say their "first priority" is to appoint a new head American consortium, led by Cavenagh and 49ers Enterprises, are now in charge at Ibrox after buying a majority stake in the club and have pledged to invest £20m this Thelwell, who will officially join as sporting director from Everton on Monday, has been working in the background on the search for a head coach along with the new owners, with Davide Ancelotti the frontrunner and Russell Martin also in the an open letter to fans, chairman Cavenagh and vice-chairman Marathe said: "We are proud to be entering a new chapter for this extraordinary club. This moment is the result of months of thoughtful discussions with club leadership and our shared confidence in Rangers' success going forward."To that end we'd like to tell you a bit about our thinking."Simply put - our goal is to win trophies in Scotland and be able to compete at a high level in Europe, while laying a foundation of financial sustainability for the future."As our first step, we are investing fresh capital into Rangers, which will be strategically deployed on and off the pitch."While we recognise the importance of resources, we believe that thoughtful, disciplined investment, guided by a clear strategy, is the path to enduring success."Every decision, whether sporting or business, will be made with the club's long-term success and sustainability in mind."We aim to leverage the full strength of 49ers Enterprises' sporting expertise and operational experience, and are confident in Patrick Stewart and Kevin Thelwell to lead this next phase."Our first priority together is clear: hiring a new men's head coach. That process is already well under way, and we look forward to sharing more updates soon. We will also look to invest in talent for our teams."Moving forward, we are reconstituting the board to bring in a few new voices and skill-sets. We all owe a special thanks to the previous board for their service. They stepped up in a difficult moment when the club needed them and laid the foundation for what comes next."Above all, we know that true success comes from understanding and honouring what makes this club special. In our time getting to know Ibrox, Glasgow, and you, we've felt the pride, history, and passion that set Rangers apart."You have made it clear what this club means to you, and we take the responsibility of leading this club seriously."
The Independent
an hour ago
- The Independent
AI to help more patients get prostate cancer drug that cuts risk of death
AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers have said. A recent study found that AI can identify patients who will benefit most from Abiraterone, a "game changer" drug. Abiraterone, a hormone therapy, functions by blocking testosterone production to prevent the growth of prostate cancer. It is approved for NHS use in England for patients with advanced prostate cancer that has spread. However, despite being available in Scotland and Wales for the past two years, it is not approved for men newly diagnosed with high-risk prostate cancer that has not yet spread. The new test, developed by Artera, uses AI to detect features invisible to the human eye on images of tumour samples. The study, led by The Institute of Cancer Research, London, and University College London (UCL), ran the test on biopsy images from more than 1,000 men who took part in the Stampede trial. Patients were given a score of either biomarker-positive or biomarker-negative. Researchers found abiraterone reduced the risk of death among biomarker-positive patients from 17 per cent to 9 per cent. In biomarker-negative patients, the drug cut death risk from 7 per cent to 4 per cent, with researchers suggesting this indicates these men would benefit from standard therapy. Nick James, a professor of prostate and bladder cancer research at The Institute of Cancer Research, London, and consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, is chief investigator of Stampede and co-led the new study. He said: 'This research shows that we can pick out the people who will respond best to abiraterone, and those who will do well from standard treatment alone – hormone therapy and radiotherapy. ' Access to this life-extending drug is currently a postcode lottery – with those living in Scotland and Wales able to receive the treatment for free. 'The NHS in England has previously decided that it would be too expensive to offer the drug. Since the patent expired in 2022, abiraterone costs just £77 per pack – compared with the thousands of pounds that new drugs cost. 'Previous research by my team has shown that preventing cancer relapses for these men would save more money than the drug costs to purchase. 'I truly hope that this new research – showing precisely who needs the drug to live well for longer – will lead to NHS England reviewing their decision not to fund abiraterone for high-risk prostate cancer that has not spread.' Prof James also highlighted that while abiraterone can have 'spectacular' results, it does have side effects. 'Abiraterone has already hugely improved the outlook for hundreds of thousands of men with advanced prostate cancer,' he said. 'We know that for many men with cancer that has not yet spread, it can also have spectacular results. 'But it does come with side effects and requires additional monitoring for potential issues with high blood pressure or liver abnormalities. 'It can also slightly increase the risk of diabetes and heart attacks, so knowing who is most likely to benefit is very valuable.' Experts hope the findings, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, may lead to a change in the availability of abiraterone in England. Prof Kristian Helin, chief executive of The Institute of Cancer Research, said the drug has been a 'game changer for treatment of prostate cancer'. 'Alongside our mission to find smarter, kinder treatments, we must ensure we are matching the right drugs to the right patients,' he added. 'This research, using artificial intelligence, provides an innovative route to testing prostate cancer patients to determine their treatment. 'I hope that this can be implemented so that all men with prostate cancer who will benefit from abiraterone can do so.' Dr Matthew Hobbs, director of research at Prostate Cancer UK, said: 'Prostate Cancer UK has been calling on the UK Government to approve this life-saving, cost-effective drug for over two years. 'These exciting results suggest a way to make this an even more cost-effective approach. 'We therefore echo the researchers' urgent call for abiraterone to be made available to those men whose lives it can save – men who, thanks to this research, we can now identify more precisely than ever before.'
BBC News
an hour ago
- BBC News
Marathe takes on Rangers role
Leeds United chairman Paraag Marathe is to take up a new position at Scottish Premiership side will work in the role of the club's new vice-chairman alongside his existing position at Elland news comes after Leeds' owners, San Francisco 49ers Enterprises, completed a multi-million pound takeover at Ibrox led by private healthcare tycoon Andrew Cavenagh, who will become Rangers' has been on the Whites' board of directors for five years, serving as vice-chairman for over two years before taking on the role as was a key figure in leading the club's ownership transition to 49ers Enterprises in July 2023.
